Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Fujing Holdings Company., Limited ( (HK:2497) ) is now available.
Fujing Holdings reported revenue of about RMB191.0 million for 2025, up 4.8% from 2024, with gross profit rising to roughly RMB84.5 million and net profit improving to about RMB63.4 million. The Group’s operations involve managing biological assets, reflected in fair value adjustments that modestly affected cost of sales and profit.
Operationally, profitability strengthened due to higher revenue, better gross margins, and a swing from prior-year expected credit loss allowances to a reversal, while the absence of listing expenses also supported the bottom line. Despite the profit growth and improved operating performance, the board decided not to recommend a final dividend for 2025, indicating a preference to retain earnings that may support future business needs or investment plans.
The most recent analyst rating on (HK:2497) stock is a Buy with a HK$0.63 price target. To see the full list of analyst forecasts on Fujing Holdings Company., Limited stock, see the HK:2497 Stock Forecast page.
More about Fujing Holdings Company., Limited
Fujing Holdings Co., Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating through subsidiaries as part of a group structure. The Group generates revenue primarily from its core operating business in mainland China, where it manages biological assets and sells related products, positioning itself within an agriculture-linked or biological assets-based sector.
Average Trading Volume: 275,500
Technical Sentiment Signal: Sell
Current Market Cap: HK$250M
For an in-depth examination of 2497 stock, go to TipRanks’ Overview page.

